Skip to content

Learn

How to Check Whether a Compounded Medication Has Been Recalled

'Lack of assurance of sterility' is the most common reason compounded injectables get recalled. Here is what that phrase means and how to look up your lot.

Medically reviewed by Ryan Arvizo, FNP-C on 2026-11-15 · Updated 2026-11-15

Educational information, reviewed by Ryan Arvizo, FNP-C. Current as of November 2026.

Anything injected has to be sterile. When a pharmacy can’t show that a batch meets that bar, or testing finds a problem, the batch is recalled. Recalls are public, and you can check your own medication in a few minutes.

Where recalls are published

  • FDA’s Recalls, Market Withdrawals and Safety Alerts page carries the press-release style announcements companies post, often with lot numbers and photos.
  • FDA’s weekly Enforcement Report lists every recall once FDA has classified it, searchable by product name, firm or recall number. This is the more complete record.

What the recall classes mean

FDA sorts recalls by risk (FDA, Recalls Background and Definitions):

  • Class I: “a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.”
  • Class II: use “may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
  • Class III: use “is not likely to cause adverse health consequences.”

The phrases you will see in compounded-drug recalls

Our regulatory tracker reads FDA’s recall data every day. In compounded injectables, the same reasons come up again and again (FDA Enforcement Report data via openFDA):

  • “Lack of assurance of sterility.” The pharmacy could not demonstrate the batch was made under sterile conditions. It is not proof of contamination, but it removes the guarantee that matters most for an injection. This is the most common reason we see.
  • “Microbial contamination” or “elevated endotoxin levels.” Testing found a problem. For example, a compounded injectable recall that FDA reported in October 2025 was classified Class I for elevated endotoxin levels (FDA recall D-0094-2026).
  • “Subpotent” or “superpotent.” The dose in the vial did not match the label.

For a real example of how a recall unfolds, see what happened with compounded glutathione injections in 2026.

How to check your own vial

  1. Find the pharmacy name, product, strength and lot number on your vial or the pharmacy label.
  2. Search the Enforcement Report for the pharmacy’s name or the product. Then check FDA’s recalls page for a recent announcement.
  3. Compare lot numbers. A recall usually covers specific lots, not every vial a pharmacy ever made.
  4. If your lot is listed, stop using it and contact the clinic that prescribed it. Do not throw it away until you have asked; they may need the lot details.
  5. If you had a reaction (fever, chills, redness or swelling at the injection site, dizziness), contact your clinician, seek emergency care for severe symptoms, and consider reporting it to FDA’s MedWatch.

How BioPeakRx handles it

Every BioPeakRx prescription is prepared by a state-licensed U.S. pharmacy for one patient. Our regulatory tracker checks FDA recall data daily.

Sources

This information is educational and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not FDA-approved. Treatments require evaluation by a licensed provider.

Have questions about whether a therapy is right for you? Start with a provider.

Start — Free Provider Evaluation← All articles

LegitScript-certifiedState-licensed U.S. pharmaciesRyan Arvizo, FNP-C9 statesNo cart, no membership fee

Member
login
Start — Free Provider Evaluation